Followers | 3352 |
Posts | 85510 |
Boards Moderated | 5 |
Alias Born | 10/05/2005 |
![](https://investorshub.advfn.com/uicon/61470.png?cb=1519141661)
Wednesday, August 14, 2019 8:22:04 AM
This opportunity came to CHNC due to the fact that it has opened its Houston Stem Cell Clinic, Inc., which is a wholly owned Subsidiary of China Infrastructure Construction Corp.
Houston Stem Cell Clinic Inc will offer Stem Cell therapy to patients of Hippocrates Direct Health Care, Inc. and CHNC. L. Natalie Carroll, M.D. will administer and treat Stem Cell patients. Dr. Carroll is an OB/GYN Physician on staff at the clinic. Elizabeth Hernandez, President and CEO of CHNC, said, “We believe our addition of Stem Cell Therapy to our clinic will bring the best care, modern technology and opportunities to CHNC as well to a large segment of Houston and dramatically increase our number of patients and increase our earned revenues.”
Hippocrates Direct Healthcare Inc, is a wholly owned subsidiary of CHNC, maintains a medical office and also does clinical research for pharmaceutical companies. Hippocrates is now moving its membership-based model into a unique surgical sub-specialty of medicine. As a Houston-based medical office we feel we will be well positioned to bring STEM CELL medicine to Houston and continue our march towards bringing our patients quality and value in all aspects of medicine,” said President & CEO Elizabeth Hernandez.
Stem-cell therapy is the use of stem cells to treat or prevent a disease or condition. Bone marrow transplant is the most widely used stem-cell therapy, but some therapies derived from umbilical cord blood are also in use.
Safe Harbor Statement
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.
Hippocrates Direct Healthcare™ and the Hippocrates Direct Healthcare™ logo are all trademarks or registered trademarks of Hippocrates Direct Healthcare™, Inc.
Elizabeth Hernandez, President/CEO
Phone: 832-606-7500
![](http://investorshub.advfn.com/uimage/uploads/2019/8/7/aojprchina-inf.png)
Give Me A Follow If You Want To Consistently Find Winners!
Click Here:
https://investorshub.advfn.com/boards/profilea.aspx?user=61470
Please do your own DD...All my posts are my opinion only!
Recent CBIH News
- Novel Cannabis Patents Livening Up Monday Morning Trading • AllPennyStocks.com • 07/01/2024 04:06:00 PM
- FINRA Announces Approval for Corporate Name Change From "China Infrastructure Construction Corp." to "Cannabis Bioscience International Holdings" And Ticker Symbol Change from "CHNC" to "CBIH". • InvestorsHub NewsWire • 08/21/2023 01:00:00 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM